Adding peginterferon alfa-2a to entecavir increases HBsAg decline and HBeAg clearance - first results from a global randomized trial (ARES study)

Sonneveld M. J., Xie Q., Zhang N., Zhang Q., Tabak F., Streinu-cercel A., ...More

63rd Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), Massachusetts, United States Of America, 9 - 13 November 2012, vol.56, (Summary Text) identifier

  • Publication Type: Conference Paper / Summary Text
  • Volume: 56
  • City: Massachusetts
  • Country: United States Of America
  • Istanbul University-Cerrahpasa Affiliated: No